Hysteroscopic septum resection in patients with recurrent abortions or infertility

Size: px
Start display at page:

Download "Hysteroscopic septum resection in patients with recurrent abortions or infertility"

Transcription

1 Human Reproduction vol.13 no.5 pp , 1998 Hysteroscopic septum resection in patients with recurrent abortions or infertility Grigoris Grimbizis, Michel Camus, Koen Clasen, Herman Tournaye, Luc De Munck and Paul Devroey 1 Centre for Reproductive Medicine, University Hospital, Dutchspeaking Brussels Free University, Laarbeeklaan 101, 1090 Brussels, Belgium 1 To whom correspondence should be addressed Fifty-seven patients who underwent hysteroscopic septum resection between January 1991 and December 1996 were studied; nine patients presented with recurrent abortions, 46 with infertility (26 primary and 20 secondary), one with dysmenorrhoea and one with an asymptomatic complete septum. Their reproductive history included 78 pregnancies: 69 (88.4%) abortions, two (2.6%) ectopics, two (2.6%) preterm deliveries and five (6.4%) term deliveries. In patients with infertility, the incidence of unexplained infertility was 19.6% and the incidence of endometriosis was 26.1%. After hysteroscopic septum resection, 42 patients were interested in pregnancy. All patients with recurrent abortions conceived spontaneously. Twenty-one (63.6%) infertile patients achieved a pregnancy, 13 (61.9%) of them after treatment with various assisted reproduction techniques. The reproductive outcome after septum resection yielded 44 pregnancies, including three sets of twins and one set of triplets reduced to twins: 11 (25%) abortions, one (2.3%) ectopic pregnancy, two (4.5%) preterm deliveries (both twins), 28 (63.7%) term deliveries and two (4.5%) as-yet ongoing pregnancies. It seems that the hysteroscopic treatment of uterine septum has a beneficial effect on pregnancy outcome. A septate uterus does not seem to be an infertility factor. The achievement of pregnancy is normal in patients with recurrent abortions, while the chances of conception in patients with infertility seem to be similar to those for the general infertile population. Key words: hysteroscopy/infertility/recurrent abortions/septum resection/uterine septum Introduction Müllerian defects are observed in 3 5% of the general population, but their frequency increases between 5 and 25% in women with recurrent miscarriages, late abortions and preterm deliveries (Acién, 1997; Pellicer, 1997). Uterine septum is the most common congenital anomaly of the female reproductive tract, with an incidence of 2 3% in the general population (Ashton et al., 1988; Simon et al., 1991). Its presence is associated with poor reproductive performance, including high incidence of first and second trimester abortion, preterm delivery (often as a result of premature rupture of the membranes), as well as abnormal presentations and increased Caesarean section rates (Heinonen et al., 1982; Buttram, 1983; McShane et al., 1983; Worthen and Gonzalez, 1984; Rock and Schlaff, 1985; Stein and March, 1990; Golan et al., 1992; Fedele and Bianchi, 1995). On the other hand, the interference of a septate uterus with the woman s fertility remains a controversial issue (Heinonen et al., 1982; Daly et al., 1989; Fedele and Bianchi, 1995; Goldenberg et al., 1995). The main and absolute indication for the treatment of patients with septate uteri is a reproductive history of recurrent abortions or fetal loss (McShane et al., 1983; DeCherney et al., 1986; Fayez, 1986; Valle and Sciarra, 1986; March and Israel, 1987; Candianni et al., 1991; Vercellini et al., 1993; Fedele and Bianchi, 1995). However, a group of patients with septate uteri may present with infertility, primary or secondary, and this will be discovered only during the infertility work-up (Fayez, 1986; Perino et al., 1987; Daly et al., 1989; Goldenberg et al., 1995). Hysteroscopic metroplasty in this group is applied mainly as a prophylactic procedure to prevent spontaneous abortions and complications during labour (Daly et al., 1989; Fedele and Bianchi, 1995). The transcervical route for the treatment of the septate uterus was initially proposed in 1884 by Ruge, but was later abandoned in favour of abdominal procedures. The introduction of operative hysteroscopy has renewed interest in the transcervical approach. In 1974, Edstrom performed the first hysteroscopic section of uterine septum, and in 1981 Chervenak and Neuwirth reported the first successful reproductive outcome after hysteroscopic metroplasty. Nowadays, the septate uterus can be effectively treated by operative hysteroscopy (Jacobsen and DeCherney, 1997). The incision of the septum can be carried out by scissors, resectoscope or laser, with no obvious advantage from any of these techniques (Candianni et al., 1991; Vercellini et al., 1993; Fedele and Bianchi, 1995; Goldenberg et al., 1995). The aim of this study was to assess the achievement of pregnancy as well as the reproductive outcome after hysteroscopic septum resection in women with recurrent abortions or infertility. Materials and methods Patients In all, 57 patients who underwent hysteroscopic septum resection from January 1991 until December 1996 were included in the study. The patients mean age was 31 5 years (range 22 45). The diagnosis of the uterine septum was based on a combination of 1188 European Society for Human Reproduction and Embryology

2 Hysteroscopic septum resection hysteroscopy and laparoscopy (although in some cases a hysterosalpingography was also available), in order to differentiate between complete septate uterus (American Fertility Society class V a ) and uterus didelphys (class III) or between partially septate uterus (class V b ) and bicornuate uterus (class IV) (American Fertility Society, 1988). Laparoscopy also allowed a more objective assessment of the patient s status in cases of infertility. The uterine septa were classified as class V a in 12 (21%) patients and as class V b in 45 (79%) patients (Table I). The preoperative reproductive performance included 78 pregnancies; 69 (88.4%) ended in abortion ( 24 weeks of gestation), two (2.6%) were ectopic, two (2.6%) ended in preterm deliveries ( 37 weeks of gestation) and only five (6.4%) were term deliveries ( 37 weeks of gestation). Indications The patients were also studied in terms of their main clinical problem. Infertility Forty-six out of 57 patients presented with infertility; 26 with primary infertility and 20 with secondary infertility (Table II). The patients mean age and the mean duration of infertility are shown in Table II. The diagnosis of the septum was made during their infertility investigation. The uterine septa were classified as class V a in 10 (21.7%) patients and as class V b in 36 (78.3%); seven (26.9%) out of 26 patients with primary infertility and three (15%) out of 20 with Table I. Reproductive performance in women with uterine septa before resection Infertility Recurrent Others Total abortions Patients (n) Type V a (n) (21.0) V b (n) (79.0) Age (years) (mean SD) Pregnancies (n) 45 a Abortions (n) 40 (88.9) 29 (87.9) 69 (88.4) Ectopics (n) 1 (2.2) 1 (3.0) 2 (2.6) Preterm deliveries (n) 0 (0.0) 2 (6.1) 2 (2.6) Term deliveries (n) 4 (8.9) 1 (3.0) 5 (6.4) a Patients with secondary infertility; V a complete septate uterus; V b partial septate uterus; n, number. Values in parentheses are percentages. secondary had a class V a septum, while the rest had a class V b septum (Table II). All couples with infertility underwent a thorough evaluation of their problem before their treatment. In all, 37 (80.4%) out of 46 patients with infertility had one or more other infertility factors, while in nine (19.6%) cases the infertility was unexplained. The number of couples with other infertility factors was significantly higher in patients with primary infertility than in those with secondary infertility: 25 (96.5%) out of 26 and 12 (60%) out of 20 respectively (P 0.05). Interestingly, 12 (26.1%) out of 46 patients had laparoscopic findings of endometriosis, seven (26.9%) out of 26 women with primary infertility and five (25%) out of 20 with secondary infertility. Twenty (43.5%) out of 46 patients had been previously treated by various assisted reproduction techniques for their infertility problem, 14 (53.8%) out of 26 patients with primary infertility and six (30%) out of 20 with secondary infertility (Table II). The numbers of these assisted reproduction technique cycles are shown in Table II. The patients with primary infertility had received less advanced therapy than those with secondary infertility, since the numbers of in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles were and respectively (P 0.05). The reproductive history of the women with secondary infertility was poor. They had achieved 45 pregnancies before septum resection: 40 (88.9%) of these had ended in spontaneous abortions, one (2.2%) had been ectopic and only four (8.9%) had ended in term deliveries (Table I). Recurrent abortions Nine out of 57 patients presented with recurrent abortions (two or more previous miscarriages). The women s mean age was years. All patients had undergone a complete work-up for their clinical problem. The diagnosis of uterine septum was made during their evaluation. The uterine septa were classified as class V b in all patients (Table I). The reproductive history included 33 pregnancies: 29 (87.9%) of these had been abortions, one (3%) had been an ectopic pregnancy, two (6.1%) had ended in preterm deliveries and only one (3%) had ended in a term delivery (Table I). Other indications Two out of 57 patients were treated for other clinical problems. Both had a class V a septum which in one case was combined with a vaginal septum. In the latter patient, the main clinical problem was severe dysmenorrhoea. In the other patient, the diagnosis of the septum was made by chance and the septum resection was applied as a prophylactic Table II. Clinical characteristics of patients with infertility Primary Secondary Total a versus b infertility a infertility b Patients (n) Type V a (n) 7 (26.9) 3 (15) 10 (21.7) NS V b (n) 19 (73.1) 17 (85) 36 (78.3) NS Age (years) (mean SD) NS Duration of infertility (mean SD) NS (years) Other infertility factors (n) 25 (96.2) 12 (60.0) 37 (80.4) P factor (n) factors (n) Patients with ART (n) 14 (53.8) 6 (30.0) 20 (43.5) cycles (mean SD) NS not significant; V a complete septate uterus; V b partial septate uterus; n number; ART assisted reproductive treatment. Values in parentheses are percentages. 1189

3 G.Grimbizis et al. procedure, taking into account the wishes of the couple for an uneventful course of a subsequent pregnancy. Procedure The hysteroscopic incision of the uterine septum was scheduled either in the early proliferative phase or after pretreatment of the patients with gonadotrophin-releasing hormone agonists. In the beginning, the operation was performed under general anaesthesia and laparoscopic control. However, the general anaesthesia was later replaced by epidural and the simultaneous laparoscopic control has been abandoned as experience has gradually increased. The cervix was dilated to 10 mm, and then a 4 mm/12 rigid hysteroscope (model A2011A; Olympus, Winter and IBE GMBH, Hamburg, Germany) mounted with a rotatable 9 mm resectoscope (Olympus models A4720, A4721, A2751, A2183, A2193) was introduced. The uterine cavity was distended with a sorbitol 5% solution (Baxter B7850, Lessines, Belgium). The septum resection was performed with an angled electrode at 90, equidistantly between the anterior and the posterior wall. After visualization of the tubal ostia, the resection was started from the lower margin of the septum and continued upwards with progressive horizontal incisions in the midline. The incision was considered complete when a normal cavity was obtained and the hysteroscope could be moved freely from one tubal ostium to the other without an intervening obstruction (March and Israel, 1987; Fedele et al., 1993; Vercellini et al., 1993; Fedele and Bianchi, 1995). In cases of complete septate uterus, the uterine septum was removed, starting from the cervical part with scissors and followed by hysteroscopic resection of the intrauterine part (Donnez and Nisolle, 1997). Although some authors believe that it is better not to remove the cervical part in order to prevent cervical incompetence (Daly et al., 1989; Römer and Lober, 1997), we do not agree with this hypothesis, as also supported by Donnez and Nisolle (1997). Postoperatively, the patients received a contraceptive pill for 2 months. A second-look hysteroscopy, on an outpatient basis, under local anaesthesia, was performed 2 or 3 months after the operation. Statistics The differences between the variables were compared using the unpaired Student s t-test or the χ 2 test, where appropriate. Results All septa were successfully removed. During the procedure, two operations were complicated by small perforations that did not require any further treatment. Follow-up after surgery was done either in the outpatient clinic or by phone to evaluate the interest in pregnancy, the achievement of pregnancy and the reproductive outcome. A patient was considered for inclusion if: (i) she could be reached either directly or by phone, (ii) she wanted to conceive and (iii) she had had 12 months of unprotected intercourse or at least one assisted reproductive treatment cycle, irrespective of the follow-up period. Forty-two out of 57 patients were included; five were lost to follow-up, six did not wish to conceive (personal, social or medical reasons) and in four cases the follow-up period was too short. The mean period of follow-up, for those interested in pregnancy, was months. Thirty (71.4%) out of 42 became pregnant; 17 spontaneously and 13 after various assisted reproductive treatments (Table III). In all, 44 pregnancies ensued, including three twins and one 1190 triplet later reduced to a twin. Eleven (25%) pregnancies ended in abortion; including one pregnancy after frozen embryo transfer and one abortion occurring shortly after amniocentesis. One (2.3%) pregnancy was ectopic. Two (4.5%) pregnancies, both twins, ended in preterm deliveries. Twenty-eight (63.7%) pregnancies ended in term deliveries, including one twin gestation and one triplet reduced to twin. Two (4.5%) are still ongoing; one of them 24 weeks of gestation. Patients with infertility Thirty-three out of 46 patients were included; 19 out of 26 with primary infertility and 14 out of 20 with secondary infertility. Four (three with primary and one with secondary infertility) were lost to follow-up, five (three with primary and two with secondary infertility) did not wish to become pregnant and four (one with primary and three with secondary) had too short follow-up period of unprotected intercourse. The mean follow-up period was months; for patients with primary infertility and for patients with secondary infertility (Table III). Postoperatively, 26 (78.8%) out of 33 patients were treated by various assisted reproductive treatments (Table III). The numbers of assisted reproductive treatment cycles according to the different types of infertility are shown in Table III. Twenty-one (63.6%) out of 36 patients achieved a pregnancy; 11 (57.9%) out of 19 patients with primary infertility and 10 (71.4%) out of 14 with secondary. Thirteen (63.6%) out of 21 pregnant women conceived after treatment with assisted reproductive treatment; eight (72.7%) out of 11 patients with primary infertility and five (50%) out of 10 with secondary infertility. In all, 34 pregnancies ensued, including three twins and one triplet reduced to a twin; 16 by women with primary infertility and 18 by those with secondary infertility (Table III). Ten (29.4%) out of 34 pregnancies ended in abortions, including one after frozen embryo transfer and one shortly after amniocentesis; four (25%) out of 16 pregnancies in patients with primary infertility and six (33.3%) out of 18 in patients with secondary infertility. One ectopic pregnancy was observed in a patient with primary infertility. Two (4.5%) twin pregnancies ended in preterm deliveries, each in one group. Nineteen (55.9%) out of 34 pregnancies ended in term deliveries; 10 (62.5%) out of 16 in patients with primary infertility and nine (50%) out of 18 in patients with secondary infertility. Two (5.9%) pregnancies are still ongoing in patients with secondary infertility; one of them is 24 weeks of gestation (Table III). Patients with recurrent abortions Eight out of nine patients were included, while one was lost to follow-up. The mean period of follow up was months. All women became pregnant spontaneously. In all, nine pregnancies ensued (Table III). One (11.1%) ended in abortion and eight (88.9%) ended in term deliveries. Others The patient with severe dysmenorrhoea was not interested in pregnancy but the hysteroscopic septum resection resulted in a significant improvement of her clinical problem. The remaining

4 Hysteroscopic septum resection Table III. Reproductive outcome of women after septum resection Primary Secondary Recurrent Others Total infertility infertility abortions Patients (n) Interest in pregnancy (n) Others 1. Lost to follow-up (n) No interest (n) Too short follow-up period (n) Follow-up (months) (mean SD) Patients with ART (n) 17 (89.5) 9 (64.3) (78.8) cycles (mean SD) Pregnant (n) 11 (57.9) 10 (71.4) 8 (100.0) 1 30 (71.4) Spontaneously (n) 3 (27.3) 5 (50.0) 8 (100.0) 1 17 (56.7) After ART (n) 8 (72.7) 5 (50.5) 0 (0.0) 0 13 (43.3) Pregnancies (n) twins 1 twin 3 twins 1 triplet-red 1 triplet-red Abortions (n) 4 (25.0) 6 (33.3) 1 (11.1) 0 11 (25.0) 1 FRET 1 FRET 1 amniocent 1 amniocent Ectopics (n) 1 (6.2) 0 (0.0) 0 ( (2.3 Preterm deliveries (n) 1 (6.2) 1 (5.6) 0 (0.0) 0 2 (4.5) 1 twin 1 twin 2 twins Term deliveries (n) 10 (62.5) 9 (50.0) 8 (88.9) 1 28 (63.7) 1 twin 1 triplet-red 1 twin 1 triplet-red Ongoing (n) 2 (11.1) 2 (4.5) 1 24 weeks 1 24 weeks NS not significant; FRET frozen embryo transfer; triplet-red triplet reduced to twin; n number; ART assisted reproductive treatment. Values in parentheses are percentages. patient achieved a spontaneous pregnancy which ended in a term delivery (Table III). Discussion The American Fertility Society (1988), based on the previous work by Buttram and Gibbons (1979), classified the anomalies of the female reproductive tract according to the degree of failure of normal development into groups with similar clinical manifestations, treatment and possible prognoses for their reproductive performance. The various Müllerian anomalies are the consequence of four major disturbances in the development of the female genital system during fetal life: (i) failure of one or more Müllerian ducts to develop (agenesis class I; unicornuate uterus without rudimentary horn class II d ), (ii) failure of the ducts to canalize (unicornuate uterus with rudimentary horn without proper cavities class II a c ), (iii) failure to fuse or abnormal fusion of the ducts (uterus didelphys class III; bicornuate uterus class IV), and (iv) failure of reabsorption of the midline uterine septum (septate uterus class V a,b ; arcuate uterus class VI). The identification of these anomalies has historically been made by hysterosalpingography, but this approach allows only the diagnosis of a double uterus (Buttram, 1983; Rock and Schlaff, 1985; Fedele and Bianchi, 1995). An accurate diagnosis should also be based on the estimation of the uterine serosal surface. Thus, a combination of laparoscopy and hysteroscopy, which is the diagnostic approach used in this study, seems to be necessary for the precise classification of uterine malformations (Buttram, 1983; Rock and Schlaff, 1985; Fedele and Bianchi, 1995). Nevertheless, some authors have reported the use of abdominal ultrasonography in the luteal phase for the differential diagnosis of double uterus (Fedele et al., 1988; Fedele and Bianchi, 1995). Although congenital uterine malformations are associated with poor reproductive performance, each type may have a different impact on reproduction (Buttram, 1983). Unicornuate uterus and uterus didelphys seem to have a similar effect on pregnancy outcome, since uterus didelphys may be considered as a symmetrical duplication of a unicornuate uterus (Buttram, 1983; Moutos et al., 1992; Marcus et al., 1996). Bicornuate and septate uterus may also be considered another group, characterized generally by poorer reproductive performance (Buttram, 1983; Rock and Schlaff, 1985; Marcus et al., 1996). In patients with septate uteri, Buttram (1983) has reported a 67% abortion rate, 33% prematurity and 28% live births. The preoperative reproductive performance in our study population was characterized by an 88.5% abortion rate and only 6.4% term delivery rate. High miscarriage rates and low term delivery rates have also been described by several authors in patients with septate uteri before metroplasty (McShane et al., 1983; Fayez, 1986; March and Israel, 1987; Perino et al., 1987; Choe and Baggish, 1992). Several mechanisms have been proposed to explain the adverse effect of a septate uterus on the course of pregnancy. The diminished size of the uterine cavity as well as cervical 1191

5 G.Grimbizis et al. incompetence have been suggested as possible aetiological factors (Fedele and Bianchi, 1995; Marcus et al., 1996). However, according to the most widely accepted theory, the septum is thought to consist of fibroelastic tissue with inadequate vascularization and altered relations between myometrial and endometrial vessels, thus exerting a negative effect on fetal placentation (Buttram, 1983; Fayez, 1987; Fedele et al., 1989; Fedele and Bianchi, 1995). Contrary to this classical concept, Dabirashrafi et al. (1995) found significantly less connective tissue, a higher amount of muscle tissue and more vessels in the septum. Thus, they suggested that pregnancy wastage is caused by poor decidualization and placentation, due to the reduced amounts of connective tissue, as well as by higher or uncoordinated contractility due to the increased muscle content. In our study population, the hysteroscopic resection of the septum was accompanied by a significant improvement in pregnancy outcome: the abortion rate dropped to 25% and the term delivery rate increased to 63.7%, while 4.5% of the pregnancies are still ongoing. It is possible that the type of conception in our patients might have a negative influence on the results: 13 (43.3%) out of 30 patients conceived after various assisted reproductive treatments and it is known that these pregnancies have unusually high abortion rates, approximating 20% (Testart et al., 1992). Moreover, one pregnancy ended in abortion shortly after amniocentesis, probably as a result of a complication from this procedure, while two twin pregnancies ended in preterm deliveries, which is also expected. A significant improvement in pregnancy outcome after hysteroscopic metroplasty was also described by other investigators, with postoperative abortion rates between 5 and 20% and live birth rates between 73 and 87% (Fayez, 1986; Valle and Sciarra, 1986; March and Israel, 1987; Perino et al., 1987; Daly et al., 1989; Choe and Baddish, 1992; Fedele et al., 1993; Jacobsen and DeCherney, 1997). However, this is only a retrospective analysis and the absence of a control group (consisting of patients with symptomatic untreated septate uterus) represents a serious limitation in the more precise evaluation of the efficacy of the hysteroscopic metroplasty, but the assisted reproductive treatment procedures done before and after the operation were exactly the same and the improvement of pregnancy outcome seems to be really impressive, as also described by Fedele and Bianchi (1995). The achievement of pregnancy is another important parameter in estimating the effect of hysteroscopic metroplasty on reproduction. In our group, all patients with recurrent abortions and normal fertility who were interested in pregnancy conceived spontaneously at least once after their treatment. Daly et al. (1989) have reported normal postoperative monthly fecundity rates. Thus, it seems that the application of hysteroscopic metroplasty does not impair the fertility potential of the women with a history of recurrent abortions. Although hysteroscopic metroplasty seems to be indicated in patients with recurrent abortions and normal fertility, in view of its efficacy and the absence of any harmful effect on the achievement of pregnancy, there is always a debate concerning the patients presenting with infertility (Fedele and Bianchi, 1995; Marcus et al., 1996). Patients with secondary 1192 infertility usually have a history of spontaneous abortions, and hysteroscopic metroplasty is applied as a treatment for their poor reproductive performance (March and Israel, 1987; Choe and Baggish, 1992; present study). On the other hand, in patients with primary infertility, hysteroscopic treatment is applied as a prophylactic procedure. The application of hysteroscopic septum resection in our patients with primary infertility was accompanied by a 25% abortion rate and 62.5% termdelivery rate. It should be noted that eight (72.7%) out of 11 patients conceived after assisted reproductive treatment and one abortion was observed shortly after amniocentesis. The results should be considered to be at least satisfactory when compared with the poor reproductive performance of the women with secondary infertility before their treatment. Moreover, Marcus et al. (1996) observed increased abortion and preterm delivery rates as well as low term delivery rates in patients with bicornuate and septate uterus presenting with primary infertility and treated by in-vitro fertilization without previous correction of the congenital anomaly. The interference of the septate uterus with infertility is another debatable issue. A possible contribution from the uterine septum can only be suggested in patients with unexplained infertility. In our study, other factors of infertility were not detected in 19.6% of the patients with infertility. This prevalence of unexplained infertility is similar to that observed in the general infertile population (ESHRE Capri Workshop, 1996). These data do not support the notion that uterine septum is a factor in infertility. On the other hand, the incidence of unexplained infertility was significantly higher (40%) in the patients with secondary infertility. Thus, a contribution from the uterine septum in delayed conception of patients with secondary infertility cannot be excluded. Although many investigators have reported the hysteroscopic treatment of infertile women (Fayez, 1986; March and Israel, 1987; Perino et al., 1987; Daly et al., 1989; Choe and Baddish, 1992; Fedele et al., 1993; Goldenberg et al., 1995), the data on infertility factors are rather limited and, where mentioned, the number of patients is low (Fayez, 1986; Perino et al., 1987; Daly et al., 1989). In our population 12 (26.1%) out of 46 patients with infertility had laparoscopic findings of endometriosis. Fedele et al. (1993) also found endometriosis in 11 (35%) out of 31 patients with uterine septum and infertility, and Fayez (1986) found this in three (45%) out of seven patients. The achievement of pregnancy in patients with uterine septum and infertility is also important. Marcus et al. (1996) have reported the treatment of 24 patients with various congenital anomalies by in-vitro fertilization without previous metroplasty; 19 (70.8%) of them became pregnant after a mean of 2.1 attempts/patient, while the pregnancy rates were similar irrespective of the type of anomaly. In another study, Guirgis and Shrivastar (1990) treated 14 patients with bicornuate uterus by gamete intra-fallopian transfer without previous metroplasty; eight (51.7%) of them achieved a pregnancy after a mean of 2.1 attempts/patient. The ovarian response to stimulation, the implantation rates and the pregnancy rates observed in these two studies were similar to those for the general infertile population. In our patients with uterine septum and infertility, 21 (63.6%) out of 33 conceived after hystero-

6 Hysteroscopic septum resection scopic metroplasty; most of them (78.8%) were treated with various assisted reproductive treatment, while many (43.5%) had a long history of previous assisted reproductive treatment cycles. Furthermore, Daly et al. (1989) reported that seven (53.8%) out of 13 patients with infertility conceived after septum resection and, more recently, Goldenberg et al. (1995) have observed pregnancies after hysteroscopic metroplasty in 18 (54%) out of 34 patients with uterine septum and infertility. Thus, the chances of conception in patients with septate uterus and infertility seem to be similar to those of the general infertile population either with or without septum resection. This may also be an indirect sign that uterine septum is not an infertility factor in itself. However, the treatment has a beneficial effect on pregnancy outcome. In conclusion, it seems that the hysteroscopic septum resection is accompanied by a significant improvement in the reproductive performance of the patients. There is no adverse effect in the achievement of pregnancy in women with a history of recurrent abortions. Septate uterus does not seem to be an infertility factor, although it may contribute to the delayed natural conception of patients with secondary infertility. Patients with septate uterus and infertility should be treated mainly for the improvement of their reproductive performance and not for the enhancement of their fertility potential, especially those treated with various types of assisted reproductive treatment. Acknowledgements The authors would like to thank Mrs Caroline Vergauwe for her assistance in the collection of the data, Mr Frank Winter of the Language Education Centre for correcting the manuscript and Mrs Ann Nys for her secretarial support. References Acien, P. (1997) Incidence of Müllerian defects in fertile and infertile women. Hum. Reprod., 12, American Fertility Society (1988) The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil. Steril., 49, Ashton, D., Amin, H.K., Richart, R.M. and Neuswirth, R.S. (1988) The incidence of asymptomatic uterine anomalies in women undergoing transcervical sterilization. Obstet. Gynecol., 72, Buttram, C.V. (1983) Müllerian anomalies and their management. Fertil. Steril., 40, Buttram, V.C. Jr and Gibbons, W.E. (1979) Müllerian anomalies: a proposed classification (an analysis of 144 cases). Fertil. Steril., 32, Candianni, G.-B., Vercellini, P., Fedele, L. et al. (1991) Argon laser versus microscissors for hysteroscopic incision of uterine septa. Am. J. Obstet. Gynecol., 164, Chervenac, F.A. and Neuwirth, R.S. (1981) Hysteroscopic resection of uterine septum. Am. J. Obstet. Gynecol., 141, Choe, K.J. and Baggish, S.M. (1992) Hysteroscopic treatment of septate uterus with neodymium YAG laser. Fertil. Steril., 57, Dabirashrafi, H., Bahadori, M., Mohammad, K. et al. (1995) Septate uterus: new idea on the histologic features in this abnormal uterus. Am. J. Obstet. Gynecol., 172, Daly, C.D., Maier, D. and Soto-Albors, C. (1989) Hysteroscopic metroplasty: six years experience. Obstet. Gynecol., 73, DeCherney, H.A., Russell, B.J., Graebe, A.R. and Polan, M.-L. (1986) Resectoscopic management of Müllerian fusion defects. Fertil. Steril., 45, Donnez, J. and Nisolle, M. (1997) Endoscopic laser treatment of uterine malformations. Hum. Reprod., 12, Edstöm, K.G.B. (1974) Intauterine surgical procedures during hysteroscopy. Endoscopy, 6, ESHRE Capri Workshop (1996) Infertility revisited: the state of the art today and tomorrow. Hum. Reprod., 11, Fayez, A.J. (1986) Comparison between abdominal and hysteroscopic metroplasty. Obstet. Gynecol., 68, Fedele, L. and Bianchi, S. (1995) Hysteroscopic metroplasty for septate uterus. Obstet. Gynecol. Clin. N. Am., 22, Fedele, L., Dorta, M., Brioschi, D. et al. (1989) Pregnancies in septate uteri: outcome in relation to site of uterine implantation as determined by sonography. Am. J. Roentgenol., 152, Fedele, L., Arcaini, L., Parazzini, F. et al. (1993) Reproductive prognosis after hysteroscopic metroplasty in 102 women: life-table analysis. Fertil. Steril., 59, Golan, A., Schneider, D., Avrech, O. et al. (1992) Hysteroscopic findings after missed abortion. Fertil. Steril., 58, Goldenberg, M., Sivan, E., Sharabi, Z. et al. (1995) Reproductive outcome following hysteroscopic management of intrauterine septum and adhesions. Hum. Reprod., 10, Guirgis, R.R. and Shrivastav, P. (1990) Gamete intrafallopian transfer (GIFT) in women with bicornuate uteri. J. In Vitro Fert. Embryo Transfer, 7, Heinonen, K.P., Saarikoski, S. and Postynen, P. (1982) Reproductive performance of women with uterine anomalies. Acta Obstet. Gynecol. Scand., 61, Jacobsen, I.J. and DeCherney, A. (1997) Results of conventional and hysteroscopic surgery. Hum. Reprod., 12, March, M.C. and Israel, R. (1987) Hysteroscopic management of recurrent abortion caused by septate uterus. Am. J. Obstet. Gynecol., 156, Marcus, S., Al-Shawaf, T. and Brinsden, P. (1996) The obstetric outcome of in vitro fertilization and embryo transfer in women with congenital uterine malformation. Am. J. Obstet. Gynecol., 175, McShane, M.P., Reilly, J.R. and Schiff, I. (1983) Pregnancy outcome following Tompkins metroplasty. Fertil. Steril., 40, Moutos, M.D., Damewood, D.M., Schlaff, D.W. and Rock, A.J. (1992) A comparison of the reproductive outcome between women with a unicornuate uterus and women with a didelphic uterus. Fertil. Steril., 58, Pellicer, A. (1997) Shall we operate on Müllerian defects? An introduction to the debate. Hum. Reprod., 12, Perino, A., Mencaglia, L., Hamou, J. and Cittadini, E. (1987) Hysteroscopy for metroplasty of uterine septa: report of 24 cases. Fertil. Steril., 48, Rock, A. and Schlaff, D.W. (1985) The obstetric consequences of uterovaginal anomalies. Fertil. Steril., 43, Römer, T. and Lober R. (1997) Hysteroscopic correction of a complete septate uterus using a balloon technique. Hum. Reprod., 12, Ruge, P. (1884) Einen fall von schwangerschaft bei uterus septus. Z. Geburtshife. Gynäkol., 10, 141. Simon, C., Martinez, L., Pardo, F. et al. (1991) Müllerian defects in women with normal reproductive outcome. Fertil. Steril., 56, Stein and March (1990) Pregnancy outcome in women with Müllerian duct anomalies. J. Reprod. Med., 35, Testart, J., Plachot, M., Mandelbaum, J. et al. (1992) World collaborative report on IVF ET and GIFT: 1989 results. Hum. Reprod., 7, Valle, F.R. and Sciarra, J.J. (1986) Hysteroscopic treatment of the septate uterus. Obstet. Gynecol., 67, Vercellini, P., Vendola, N., Colombo, A. et al. (1993) Hysteroscopic metroplasty with microscissors for the correction of septate uterus. Surg. Gynecol. Obstet., 176, Worthen, J.N. and Gonzalez, F. (1984) Septate uterus: sonographic diagnosis and obstetric complications. Obstet. Gynecol., 64, Received on July 7, 1997; accepted on January 30,

Lecture 2 Advanced Hysteroscopic Surgery

Lecture 2 Advanced Hysteroscopic Surgery Lecture 2 Advanced Hysteroscopic Surgery Dubai BSGE Approved Course Mr N Panay Consultant Gynaecologist & Honorary Senior Lecturer Hammersmith Hospitals NHS Trust & Imperial College London Advanced Hysteroscopic

More information

The position of hysteroscopy in current fertility practice is under debate.

The position of hysteroscopy in current fertility practice is under debate. The position of hysteroscopy in current fertility practice is under debate. The procedure is well tolerated. No consensus on effectiveness of HSC in improving prognosis of subfertile women. systematic

More information

Ultrasound and Hysteroscopy in Infertility

Ultrasound and Hysteroscopy in Infertility Ultrasound and Hysteroscopy in Infertility James M. Shwayder, M.D., J.D. Professor and Chair Department of Obstetrics and Gynecology University of Mississippi Medical Center Jackson, Mississippi Ultrasound

More information

The following chapter is called The Role of Endoscopy, Laparoscopy, and Hysteroscopy in Infertility.

The following chapter is called The Role of Endoscopy, Laparoscopy, and Hysteroscopy in Infertility. Welcome to Chapter 14. The following chapter is called The Role of Endoscopy, Laparoscopy, and Hysteroscopy in Infertility. The authors are Dr. Jose Remohi and Dr. Jaime Ferro. 1 There are several tools

More information

CHAPTER 10 Uterine Synechiae

CHAPTER 10 Uterine Synechiae CHAPTER 10 Uterine Synechiae Uterine synechiae are intrauterine adhesions. They may involve small focal areas of the endometrium (Figures 10.1a e), or they can be so extensive that they obliterate the

More information

Hysteroscopic evaluation in infertile patients: a prospective study

Hysteroscopic evaluation in infertile patients: a prospective study International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sahu L et al. Int J Reprod Contracept Obstet Gynecol. 2012 Dec;1(1):37-41 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Hysteroscopic Metroplasty for the Septate Uterus: Review and Meta-Analysis

Hysteroscopic Metroplasty for the Septate Uterus: Review and Meta-Analysis Review Article Hysteroscopic Metroplasty for the Septate Uterus: Review and Meta-Analysis Rafael F. Valle, MD*, and Geraldine E. Ekpo, MD From the Department of Obstetrics and Gynecology, Northwestern

More information

SUBSEROSAL FIBROIDS TREATMENT

SUBSEROSAL FIBROIDS TREATMENT INTRODUCTION Uterine fibroids, also known as leiomyomas, are the most common pelvic mass found in women. Fibroids are benign tumors that arise from the uterine muscular tissue (myometrium). They occur

More information

Implementation of hysteroscopy in an infertility clinic: The one-stop uterine diagnosis and treatment

Implementation of hysteroscopy in an infertility clinic: The one-stop uterine diagnosis and treatment Facts Views Vis Obgyn, 2014, 6 (4): 235-239 Short communication Implementation of hysteroscopy in an infertility clinic: The one-stop uterine diagnosis and treatment R. Campo 1,2,3, R. Meier,2, N. Dhont

More information

REPRODUCTIVE OUTCOME AFTER HYSTEROSCOPIC METROPLASTY IN PATIENTS WITH INFERTILITY AND RECURRENT PREGNANCY LOSS

REPRODUCTIVE OUTCOME AFTER HYSTEROSCOPIC METROPLASTY IN PATIENTS WITH INFERTILITY AND RECURRENT PREGNANCY LOSS Prilozi, Odd. biol. med. nauki, MANU, XXXII, 1, c. 141 154 (2011) Contributions, Sec. Biol. Med. Sci. MASA, XXXII, 1, p.141 154 (2011) ISSN 0351 3254 UDK: 618.14-089.844 REPRODUCTIVE OUTCOME AFTER HYSTEROSCOPIC

More information

A Guide to Hysteroscopy. Patient Education

A Guide to Hysteroscopy. Patient Education A Guide to Hysteroscopy Patient Education QUESTIONS AND ANSWERS ABOUT HYSTEROSCOPY Your doctor has recommended that you have a procedure called a hysteroscopy. Naturally, you may have questions about

More information

Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.

Welcome to chapter 2. The following chapter is called Indications For IVF. The author is Dr Kamini A. Rao. Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao. The indications for an IVF treatment have increased since the birth of the first IVF baby. The

More information

טופס הסכמה לטיפולי הפרייה חוץ גופית

טופס הסכמה לטיפולי הפרייה חוץ גופית טופס הסכמה לטיפולי הפרייה חוץ גופית CONSENT FORM: IN-VITRO FERTILIZATION (IVF) 1. General In-vitro fertilization is performed in cases of impaired fertility, which may be caused by the following: Obstruction

More information

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY 1 Nada Polyclinic, Po ega, Croatia 2 School of Medicine, University of Zagreb, Zagreb, Croatia Preliminary Communication Received: April 15, 2004 Accepted: June 16, 2004 EFFECT OF INCREASED TESTOSTERONE

More information

GYNAECOLOGY. Ahmed Mohamed Abbas*, Mohamed Khalaf*, Abd El-Aziz E. Tammam**, Ahmed H. Abdellah**, Ahmed Mwafy**. Introduction ABSTRACT

GYNAECOLOGY. Ahmed Mohamed Abbas*, Mohamed Khalaf*, Abd El-Aziz E. Tammam**, Ahmed H. Abdellah**, Ahmed Mwafy**. Introduction ABSTRACT Thai Journal of Obstetrics and Gynaecology April 2015, Vol. 23, pp. 113-117 GYNAECOLOGY The Diagnostic Value of Saline Infusion Sonohysterography Versus Hysteroscopy in Evaluation of Uterine Cavity in

More information

Management fertility sparing degli endometriomi Errico Zupi

Management fertility sparing degli endometriomi Errico Zupi Management fertility sparing degli endometriomi Errico Zupi Università Tor Vergata Roma Management of endometrioma Pain Infertility Surgical treatment Medical treatment Infertility clinic Both medical

More information

Asherman syndrome is an acquired

Asherman syndrome is an acquired Comprehensive management of severe Asherman syndrome and amenorrhea Erinn M. Myers, M.D., a and Bradley S. Hurst, M.D. a,b a Department of Obstetrics and Gynecology and b Division of Reproductive Endocrinology,

More information

Laparoscopy and Hysteroscopy

Laparoscopy and Hysteroscopy AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of

More information

West African Journal of Assisted Reproduction (WAJAR)Vol1 No1 Available online at http://www.wajar.info/archive.html

West African Journal of Assisted Reproduction (WAJAR)Vol1 No1 Available online at http://www.wajar.info/archive.html West African Journal of Assisted Reproduction (WAJAR)Vol1 No1 Available online at http://www.wajar.info/archive.html HYSTEROSCOPY IN THE TROPICS; HOW SAFE? A REVIEW OF CLINICAL PRACTICE IN AN ASSISTED

More information

Laparoscopic management of endometriosis in infertile women and outcome

Laparoscopic management of endometriosis in infertile women and outcome International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sahu L et al. Int J Reprod Contracept Obstet Gynecol. 2013 Jun;2(2):177-181 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Risks and complications of assisted conception

Risks and complications of assisted conception Risks and complications of assisted conception August 005 Richard Kennedy British Fertility Society Factsheet www.fertility.org.uk No medical treatment is entirely free from risk and infertility treatment

More information

Uterine fibroids (Leiomyoma)

Uterine fibroids (Leiomyoma) Uterine fibroids (Leiomyoma) What are uterine fibroids? Uterine fibroids are fairly common benign (not cancer) growths in the uterus. They occur in about 25 50% of all women. Many women who have fibroids

More information

Migration of an intrauterine contraceptive device to the sigmoid colon: a case report

Migration of an intrauterine contraceptive device to the sigmoid colon: a case report The European Journal of Contraception and Reproductive Health Care 2003;8:229 232 Case Report Migration of an intrauterine contraceptive device to the sigmoid colon: a case report Ü. S. nceboz, H. T. Özçakir,

More information

STUDY OF MORPHOLOGY OF UTERUS USING ULTRASOUND SCAN

STUDY OF MORPHOLOGY OF UTERUS USING ULTRASOUND SCAN Original Article STUDY OF MORPHOLOGY OF UTERUS USING ULTRASOUND SCAN P. Priya 1, S. Vijayalakshmi * 2. 1 Associate Professor, Dept. of Anatomy, Saveetha Medical College, Chennai, Tamil Nadu, India. *2

More information

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register 1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: [email protected] Supported by the IVF Directors Group of

More information

University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.

University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate. University Hospitals Coventry and Warwickshire NHS Trust Centre for Reproductive Medicine We Care. We Achieve. We Innovate. Introduction We were the first NHS Hospital in the West Midlands to set up a

More information

Uterine fibroids: impact on fertility and pregnancy loss

Uterine fibroids: impact on fertility and pregnancy loss Uterine fibroids: impact on fertility and pregnancy loss Neelanjana Mukhopadhaya Grace Pokuah Asante Isaac T Manyonda Abstract Uterine fibroids are the most common tumours of the female genital tract.

More information

Ehlers-Danlos Syndrome Fertility Issues. Objectives

Ehlers-Danlos Syndrome Fertility Issues. Objectives Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine

More information

In - Vitro Fertilization Handbook

In - Vitro Fertilization Handbook In - Vitro Fertilization Handbook William F. Ziegler, D.O. Medical Director Scott Kratka, ELD, TS Embryology Laboratory Director Lauren F. Lucas, P.A.-C, M.S. Physician Assistant Frances Cerniak, R.N.

More information

Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging

Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging Ultrasound Obstet Gynecol 2010; 35: 593 601 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7551 Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies

More information

Patient Information: Endometriosis Disease Process and Treatment

Patient Information: Endometriosis Disease Process and Treatment 1 William N. Burns, M. D. Associate Professor Department of Obstetrics & Gynecology Joan C. Edwards School of Medicine Marshall University Huntington, West Virginia, USA Patient Information: Endometriosis

More information

Review Article What Is the Role of Hysteroscopic Surgery in the Management of Female Infertility? A Review of the Literature

Review Article What Is the Role of Hysteroscopic Surgery in the Management of Female Infertility? A Review of the Literature Surgery Research and Practice, Article ID 105412, 6 pages http://dx.doi.org/10.1155/2014/105412 Review Article What Is the Role of Hysteroscopic Surgery in the Management of Female Infertility? A Review

More information

Assisted Reproductive Technologies at IGO

Assisted Reproductive Technologies at IGO 9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area

More information

OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies

OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies OHTAC Recommendation In Vitro Fertilization and Multiple Pregnancies October 19, 2006 The Ontario Health Technology Advisory Committee (OHTAC) met on October 19, 2006 and reviewed the health technology

More information

TREATMENT OF UTERINE ANOMALIES AND REPRODUCTIVE OUTCOME

TREATMENT OF UTERINE ANOMALIES AND REPRODUCTIVE OUTCOME TREATMENT OF UTERINE ANOMALIES AND REPRODUCTIVE OUTCOME Danie Botha The Dalmeyer Fertility Unit Port Elizabeth SASOG 2014 Uterine anomalies are any abnormality of the uterus that may result from defective

More information

Endometriosis, Fertility and Pregnancy

Endometriosis, Fertility and Pregnancy This leaflet covers endometriosis and fertility. It provides information for women who have been diagnosed with endometriosis who would like to know if and how this can affect their fertility, and for

More information

Why I don t recommend endometrial ablation

Why I don t recommend endometrial ablation Why I don t recommend endometrial ablation Endometrial ablation is a major operative procedure that: o Is ineffective because, according to all research, 40% will ultimately still need a hysterectomy,

More information

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA Table of Contents 1.

More information

A potential treatment for your abnormal uterine bleeding

A potential treatment for your abnormal uterine bleeding TRUCLEAR System A potential treatment for your abnormal uterine bleeding Do You Suffer from Abnormal Uterine Bleeding? What is a Hysteroscopy? What is the TRUCLEAR Procedure? What Happens Before Your

More information

The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".

The following chapter is called Follow-ups with a Positive or a Negative Pregnancy Test. Slide 1 Welcome to chapter 7. The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test". The author is Professor Pasquale Patrizio. Slide 2 This chapter has the following

More information

A prospective evaluation of uterine abnormalities by saline infusion sonohysterography in 1,009 women with infertility or abnormal uterine bleeding

A prospective evaluation of uterine abnormalities by saline infusion sonohysterography in 1,009 women with infertility or abnormal uterine bleeding REPRODUCTIVE ENDOCRINOLOGY A prospective evaluation of uterine abnormalities by saline infusion sonohysterography in 1,009 women with infertility or abnormal uterine bleeding Ilan Tur-Kaspa, M.D., a Michael

More information

Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance

Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance Illinois Insurance Facts Illinois Department of Financial and Professional Regulation Division of Insurance Insurance Coverage for Infertility Treatment Revised November 2004 Infertility is a condition

More information

Department of Reproductive Medicine and Gynecology, St. Antonius Hospital, Nieuwegein, the Netherlands;

Department of Reproductive Medicine and Gynecology, St. Antonius Hospital, Nieuwegein, the Netherlands; The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients Janine G. Smit, M.D., a Jenneke C. Kasius, M.D., Ph.D., a Marinus J. C. Eijkemans,

More information

Basics of infertility Student Lecture Dr. A. Vilos, MD, FRCSC, Ass. Professor Department of OB/Gyn, REI Division Western University

Basics of infertility Student Lecture Dr. A. Vilos, MD, FRCSC, Ass. Professor Department of OB/Gyn, REI Division Western University Definitions Basics of infertility Student Lecture Dr. A. Vilos, MD, FRCSC, Ass. Professor Department of OB/Gyn, REI Division Western University Infertility One year of frequent unprotected intercourse

More information

CASE REPORT Double Cervix and Vagina with Septate Uterus: An Uncommon Müllerian Malformation

CASE REPORT Double Cervix and Vagina with Septate Uterus: An Uncommon Müllerian Malformation CASE REPORT Double Cervix and Vagina with Septate Uterus: An Uncommon Müllerian Malformation Andrew F. Hundley, M.D., Julia R. Fielding, M.D.*, Lennox Hoyte, M.D. Departments of Obstetrics and Gynecology

More information

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Dr Niel Senewirathne Senior Consultant of Obstetrician & Gynaecologist De zoyza Maternity Hospita 1 ART - IVF & ICSI 2 Infertility No pregnancy

More information

Fertility Facts and Figures 2008

Fertility Facts and Figures 2008 Fertility Facts and Figures 2008 Contents About these statistics... 2 Accessing our data... 2 The scale of fertility problems... 3 Treatment abroad... 3 Contacts regarding this publication... 3 Latest

More information

Treating heavy menstrual bleeding caused by fibroids or polyps

Treating heavy menstrual bleeding caused by fibroids or polyps Treating heavy menstrual bleeding caused by fibroids or polyps With today s medical advances the outlook for successful treatment of fibroids and polyps has never been better. You don t have to live with

More information

Specialists In Reproductive Medicine & Surgery, P.A.

Specialists In Reproductive Medicine & Surgery, P.A. Specialists In Reproductive Medicine & Surgery, P.A. Craig R. Sweet, M.D. www.dreamababy.com [email protected] Excellence, Experience & Ethics Endometriosis Awareness Week/Month Common Questions

More information

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Page 1 of 6 AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Age has a profound effect on female fertility. This is common knowledge,

More information

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016

More information

ENDOMETRIOSIS & INFERTILITY. Professor T C Li Sheffield

ENDOMETRIOSIS & INFERTILITY. Professor T C Li Sheffield ENDOMETRIOSIS & INFERTILITY Professor T C Li Sheffield PRESENTATIONS Pain dysmenorrhoea dyspareunia chronic pain low back iliac fossa Infertility Ovarian cyst/mass PAIN PAIN IS THE PASSION OF THE SOUL

More information

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient) Name of Patient: Name of Partner: We, the Patient and Partner (if applicable) named above, are each over the age of twenty-one (21) years. By our signatures below, I/we request and authorize the performance

More information

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although

More information

Role of Hysteroscopy and Laparoscopy in Evaluation of Abnormal Uterine Bleeding

Role of Hysteroscopy and Laparoscopy in Evaluation of Abnormal Uterine Bleeding ORIGINAL ARTICLE Role of Hysteroscopy and Laparoscopy in Evaluation of Abnormal Uterine Bleeding Jyotsana, Kamlesh Manhas, Sudha Sharma Abstract Abnormal uterine poses a real challenge for the gynecologists

More information

Interrupted Pregnancy Coding

Interrupted Pregnancy Coding Interrupted Pregnancy Coding American College of Obstetricians and Gynecologists Terry Tropin, RHIA, CPC, CCS-P, ACS-OB, PCS Content Development Expert, DecisionHealth ACOG Committee on Coding and Nomenclature

More information

Prognosis of Very Large First-Trimester Hematomas

Prognosis of Very Large First-Trimester Hematomas Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate

More information

Transvaginal Endoscopy TVE GYN 18 7.0 02/2015-E

Transvaginal Endoscopy TVE GYN 18 7.0 02/2015-E Transvaginal Endoscopy TVE GYN 18 7.0 02/2015-E TRANSVAGINAL ENDOSCOPY Leuven Institute for Fertility and Embryology Prof. Dr. S. Gordts, Dr. R. Campo, Dr. P. Puttemans, Prof. Em. Dr. I. Brosens 2 Transvaginal

More information

CONTROVERSY: LAPAROSCOPY: ANY ROLE IN THE TREATMENT OF INFERTILITY?

CONTROVERSY: LAPAROSCOPY: ANY ROLE IN THE TREATMENT OF INFERTILITY? CONTROVERSY: LAPAROSCOPY: ANY ROLE IN THE TREATMENT OF INFERTILITY? Role of laparoscopic treatment of endometriosis in patients with failed in vitro fertilization cycles Eva Littman, M.D., Linda Giudice,

More information

Sterilisation for women and men: what you need to know

Sterilisation for women and men: what you need to know Sterilisation for women and men: what you need to know Published January 2004 by the RCOG Contents Page number Key points 1 About this information 2 What are tubal occlusion and vasectomy? 2 What do I

More information

Hysteroscopy Findings in Failed IVF and its Influence on Pregnancy Outcome

Hysteroscopy Findings in Failed IVF and its Influence on Pregnancy Outcome Med. J. Cairo Univ., Vol. 79, No. 1, December: 595-599, 2011 www.medicaljournalofcairouniversity.com Hysteroscopy Findings in Failed IVF and its Influence on Pregnancy Outcome AHMED AL ZBOONE, JBOG The

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment

More information

In Vitro Fertilization (IVF) Page 1 of 11

In Vitro Fertilization (IVF) Page 1 of 11 In Vitro Fertilization (IVF) Page 1 of 11 This document is a part of your informed consent process. Both partners should read the entire document carefully. In vitro fertilization (IVF) is a treatment

More information

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance. INSURANCE DIVISION OF INSURANCE Actuarial Services Benefit Standards for Infertility Coverage Proposed New Rules: N.J.A.C. 11:4-54 Authorized By: Holly C. Bakke, Commissioner, Department of Banking and

More information

First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term

First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term Case Report First-Trimester Cesarean Scar Pregnancy Evolving Into Placenta Previa/Accreta at Term Jara Ben Nagi, MD, Dede Ofili-Yebovi, MD, Mike Marsh, MD, Davor Jurkovic, MD Placenta accreta is a rare

More information

NovaSure: A Procedure for Heavy Menstrual Bleeding

NovaSure: A Procedure for Heavy Menstrual Bleeding NovaSure: A Procedure for Heavy Menstrual Bleeding The one-time, five-minute procedure Over a million women 1 have been treated with NovaSure. NovaSure Endometrial Ablation (EA) is the simple, one-time,

More information

Reproductive Health Group

Reproductive Health Group Gynaecology Services & Treatments 2015 Fee Schedule Consultations - Assessment Initial gynaecology consultation 200-250 Follow-up gynaecology consultation 150-175 Initial fertility consultation *Harley

More information

Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer

Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer Camran Nezhat,, MD, FACOG, FACS Stanford University Medical Center Center for Special Minimally Invasive

More information

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2 August 2012 content 8 Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2 Maintaining fertility new opportunities in GENNET...3 Hysteroscopy without

More information

All you need to know about Endometriosis. Nordica Fertility Centre, Lagos, Asaba, Abuja

All you need to know about Endometriosis. Nordica Fertility Centre, Lagos, Asaba, Abuja All you need to know about Endometriosis October, 2015 About The Author Nordica Lagos Fertility Centre is one of Nigeria's leading centres for world class Assisted Reproductive Services, with comfort centres

More information

CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM

CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM I, after consultation with my physician, request to participate in the In Vitro Fertilization (IVF)-Embryo Transfer (ET) procedures

More information

Office hysteroscopy, transvaginal ultrasound and endometrial histology: a comparison in infertile patients

Office hysteroscopy, transvaginal ultrasound and endometrial histology: a comparison in infertile patients Clinical science Acta Medica Academica 2011;40(1):x-XX DOI: xxxxxxxxxxxxxxx Office hysteroscopy, transvaginal ultrasound and endometrial histology: a comparison in infertile patients Devleta Balić, Adem

More information

ESSURE REIMBURSEMENT GUIDE

ESSURE REIMBURSEMENT GUIDE ESSURE REIMBURSEMENT GUIDE A CODING AND COVERAGE RESOURCE Indication Essure is indicated for women who desire permanent birth control (female sterilization) by bilateral occlusion of the fallopian tubes.

More information

Reproductive Technology. Chapter 21

Reproductive Technology. Chapter 21 Reproductive Technology Chapter 21 Assisted Reproduction When a couple is sub-fertile or infertile they may need Assisted Reproduction to become pregnant: Replace source of gametes Sperm, oocyte or zygote

More information

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY Policy: Infertility Evaluation and Treatment Number: MM 1306 Date Effective:

More information

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014 East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2014 1 1. Introduction This policy sets out the entitlement and service that will

More information

Crohn's disease and pregnancy.

Crohn's disease and pregnancy. Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy

More information

ESHRE GUIDELINE ON MANAGEMENT OF WOMEN WITH ENDOMETRIOSIS. Is there evidence supporting surgery in endometriosis?

ESHRE GUIDELINE ON MANAGEMENT OF WOMEN WITH ENDOMETRIOSIS. Is there evidence supporting surgery in endometriosis? ESHRE GUIDELINE ON MANAGEMENT OF WOMEN WITH ENDOMETRIOSIS Is there evidence supporting surgery in endometriosis? Authors: E. Saridogan, G. Dunselman, C. Becker, Endometriosis guideline development group,

More information

Women s Health Laparoscopy Information for patients

Women s Health Laparoscopy Information for patients Women s Health Laparoscopy Information for patients This leaflet is for women who have been advised to have a laparoscopy. It outlines the common reasons doctors recommend this operation, what will happen

More information

Ectopic Pregnancy. A Guide for Patients PATIENT INFORMATION SERIES

Ectopic Pregnancy. A Guide for Patients PATIENT INFORMATION SERIES Ectopic Pregnancy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications

More information

Illinois Insurance Facts Illinois Department of Insurance

Illinois Insurance Facts Illinois Department of Insurance Illinois Insurance Facts Illinois Department of Insurance Insurance Coverage for Infertility Treatment Revised December 2014 Note: This information was developed to provide consumers with general information

More information

Safe & Unsafe. abortion

Safe & Unsafe. abortion Safe & Unsafe Facts About abortion WHAT IS THE DIFFERENCE BETWEEN UNSAFE AND SAFE ABORTION? What is unsafe abortion? Unsafe abortion is a procedure for terminating an unplanned pregnancy either by a person

More information

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 RECIPIENT COUPLE INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION

More information

Causes for unintentional childlessness

Causes for unintentional childlessness Causes for unintentional childlessness We can define fertility as the inability to become pregnant after one year of regular sexual intercourse. The causes of infertility are evenly distributed among men

More information

Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota

Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota The information provided by speakers in workshops, forums, sharing/networking

More information

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES We, the undersigned, as patient and partner understand that we will be undergoing one or more procedures

More information

Infertility: An Overview

Infertility: An Overview AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Infertility: An Overview A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the

More information

REPRODUCTIVE ENDOCRINOLOGY

REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY

More information

Hysteroscopy for Metroplasty of Uterine Septa and Hypoplastic Uterus

Hysteroscopy for Metroplasty of Uterine Septa and Hypoplastic Uterus Hysteroscopy for Metroplasty of Uterine Septa and Hypoplastic Uterus Budi R. Hadibroto Departemen Obstetri dan Ginekologi Fakultas Kedokteran Universitas Sumatera Utara RSUP H. Adam Malik RSUD Dr. Pirngadi

More information

Welcome to Cartersville Ob/Gyn Associates.

Welcome to Cartersville Ob/Gyn Associates. Welcome to Cartersville Ob/Gyn Associates. We are a full-service Ob/Gyn practice, delivering women the exceptional care, medical expertise, compassion and support they deserve through every life cycle

More information

Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery

Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic

More information

Assignment Discovery Online Curriculum

Assignment Discovery Online Curriculum Assignment Discovery Online Curriculum Lesson title: In Vitro Fertilization Grade level: 9-12, with adaptation for younger students Subject area: Life Science Duration: Two class periods Objectives: Students

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER Partner #1 Last Name (Surname): Partner #1 First Name: Partner #1 Last 5 Digits

More information